IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Accretion Pharmaceuticals IPO listing price is [●], issue price is ₹ 101.00, and currently trading at [●] as on [●]. Accretion Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Accretion Pharmaceuticals IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Jawa Capital Services is the merchant banker of Accretion Pharmaceuticals IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th January 2025.
Accretion Pharmaceuticals IPO offer price is [●] and got listed at [●]. Read Accretion Pharmaceuticals IPO details mentioned above.The IPO of Accretion Pharmaceuticals Limited was listed on 21st May 2025. As of today, Accretion Pharmaceuticals IPO is trading at [●], compared to the previous day’s close of [●]. Read the report above for detailed IPO performance.
The issue price of Accretion Pharmaceuticals IPO was ₹ 101.00 per equity share.
Accretion Pharmaceuticals IPO was listed at ₹ on the stock exchange on 21st May 2025. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of [●], the current market price of Accretion Pharmaceuticals IPO is [●].
The 52-week high for Accretion Pharmaceuticals IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Accretion Pharmaceuticals IPO listed at [●] against the issue price of ₹ 101.00 per equity share, showing a listing day gain/loss of -1 (-100.00%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Accretion Pharmaceuticals IPO stock moved from its listing price of [●] to the current price of ₹[●] per equity share, reflecting a change of 0.00% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Accretion Pharmaceuticals IPO issue date of [●] and CMP of ₹[●], the estimated CAGR is approximately 0%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
₹ 101.00
Listing Price :
[●]
Previous Day Closing
[●]
Accretion Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Accretion Pharmaceuticals Financial Review Page
Merchant Banker(s) of Accretion Pharmaceuticals IPO: Jawa Capital Services Private Limited
Accretion Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Accretion Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Accretion Pharmaceuticals is .
Why Us?
